S-Nitrosylation of Akt by organic nitrate delays revascularization and the recovery of cardiac function in mice following myocardial infarction

J Cell Mol Med. 2021 Jan;25(1):27-36. doi: 10.1111/jcmm.15263. Epub 2020 Oct 30.

Abstract

The effects of long-term nitrate therapy are compromised due to protein S-Nitrosylation, which is mediated by nitric oxide (NO). This study is to determine the role of Akt S-Nitrosylation in the recovery of heart functions after ischaemia. In recombinant Akt protein and in HEK293 cells, NO donor decreased Akt activity and induced Akt S-Nitrosylation, but was abolished if Akt protein was mutated by replacing cysteine 296/344 with alanine (Akt-C296/344A). In endothelial cells, NO induced Akt S-Nitrosylation, reduced Akt activity and damaged multiple cellular functions including proliferation, migration and tube formation. These alterations were ablated if cells expressed Akt-C296/344A mutant. In Apoe-/- mice, nitroglycerine infusion increased both Akt S-Nitrosylation and infarct size, reduced Akt activity and capillary density, and delayed the recovery of cardiac function in ischaemic hearts, compared with mice infused with vehicle. Importantly, these in vivo effects of nitroglycerine in Apoe-/- mice were remarkably prevented by adenovirus-mediated enforced expression of Akt-C296/344A mutant. In conclusion, long-term usage of organic nitrate may inactivate Akt to delay ischaemia-induced revascularization and the recovery of cardiac function through NO-mediated S-Nitrosylation.

Keywords: Akt; S-Nitrosylation; angiogenesis; myocardial infarction; organic nitrate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / metabolism
  • Amino Acid Sequence
  • Animals
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / metabolism
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Cysteine / metabolism
  • HEK293 Cells
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Mice
  • Mutation / genetics
  • Myocardial Infarction / metabolism*
  • Myocardial Infarction / physiopathology*
  • Myocardial Revascularization*
  • Neovascularization, Physiologic / drug effects
  • Nitrates / metabolism*
  • Nitric Oxide / metabolism
  • Nitroglycerin / pharmacology
  • Nitroprusside / pharmacology
  • Nitrosation
  • Proto-Oncogene Proteins c-akt / metabolism*

Substances

  • Apolipoproteins E
  • Nitrates
  • Nitroprusside
  • Nitric Oxide
  • Proto-Oncogene Proteins c-akt
  • Nitroglycerin
  • Cysteine